Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: Clinical aspects

Nathaniel M. Meier, Michael L. Foster, John T. Battaile

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder of blood vessel formation resulting in mucocutaneous telangiectasias and visceral arteriovenous malformations. Nearly half of patients with HHT will have pulmonary arteriovenous malformations (PAVM) that place them at risk for potentially fatal complications that can occur when blood bypasses the pulmonary capillary circulation or as a result of PAVM rupture. Other manifestations of HHT outside the lung may increase the rate and severity of PAVM complications, creating unique clinical challenges. Management hinges on timely screening and diagnosis, followed by treatment of amenable PAVMs with transcatheter embolization in conjunction with medical management and prophylactic measures to treat and prevent complications. The purpose of this review is to highlight the clinical manifestations of PAVMs specific to patients with HHT and to detail screening and treatment strategies that can reduce the risk of developing life-threatening complications.

Original languageEnglish (US)
Pages (from-to)316-324
Number of pages9
JournalCardiovascular Diagnosis and Therapy
Volume8
Issue number3
DOIs
StatePublished - Jun 1 2018

Fingerprint

Hereditary Hemorrhagic Telangiectasia
Arteriovenous Malformations
Lung
Telangiectasis
Inborn Genetic Diseases
Pulmonary Circulation
Blood Vessels
Rupture
Therapeutics

Keywords

  • Hereditary hemorrhagic telangiectasia (HHT)
  • Pulmonary arteriovenous malformation (PAVM)

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations : Clinical aspects. / Meier, Nathaniel M.; Foster, Michael L.; Battaile, John T.

In: Cardiovascular Diagnosis and Therapy, Vol. 8, No. 3, 01.06.2018, p. 316-324.

Research output: Contribution to journalReview article

@article{72e95396ced542b3918175b64b35a491,
title = "Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: Clinical aspects",
abstract = "Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder of blood vessel formation resulting in mucocutaneous telangiectasias and visceral arteriovenous malformations. Nearly half of patients with HHT will have pulmonary arteriovenous malformations (PAVM) that place them at risk for potentially fatal complications that can occur when blood bypasses the pulmonary capillary circulation or as a result of PAVM rupture. Other manifestations of HHT outside the lung may increase the rate and severity of PAVM complications, creating unique clinical challenges. Management hinges on timely screening and diagnosis, followed by treatment of amenable PAVMs with transcatheter embolization in conjunction with medical management and prophylactic measures to treat and prevent complications. The purpose of this review is to highlight the clinical manifestations of PAVMs specific to patients with HHT and to detail screening and treatment strategies that can reduce the risk of developing life-threatening complications.",
keywords = "Hereditary hemorrhagic telangiectasia (HHT), Pulmonary arteriovenous malformation (PAVM)",
author = "Meier, {Nathaniel M.} and Foster, {Michael L.} and Battaile, {John T.}",
year = "2018",
month = "6",
day = "1",
doi = "10.21037/cdt.2017.12.07",
language = "English (US)",
volume = "8",
pages = "316--324",
journal = "Cardiovascular Diagnosis and Therapy",
issn = "2223-3652",
publisher = "AME Publishing Company",
number = "3",

}

TY - JOUR

T1 - Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations

T2 - Clinical aspects

AU - Meier, Nathaniel M.

AU - Foster, Michael L.

AU - Battaile, John T.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder of blood vessel formation resulting in mucocutaneous telangiectasias and visceral arteriovenous malformations. Nearly half of patients with HHT will have pulmonary arteriovenous malformations (PAVM) that place them at risk for potentially fatal complications that can occur when blood bypasses the pulmonary capillary circulation or as a result of PAVM rupture. Other manifestations of HHT outside the lung may increase the rate and severity of PAVM complications, creating unique clinical challenges. Management hinges on timely screening and diagnosis, followed by treatment of amenable PAVMs with transcatheter embolization in conjunction with medical management and prophylactic measures to treat and prevent complications. The purpose of this review is to highlight the clinical manifestations of PAVMs specific to patients with HHT and to detail screening and treatment strategies that can reduce the risk of developing life-threatening complications.

AB - Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder of blood vessel formation resulting in mucocutaneous telangiectasias and visceral arteriovenous malformations. Nearly half of patients with HHT will have pulmonary arteriovenous malformations (PAVM) that place them at risk for potentially fatal complications that can occur when blood bypasses the pulmonary capillary circulation or as a result of PAVM rupture. Other manifestations of HHT outside the lung may increase the rate and severity of PAVM complications, creating unique clinical challenges. Management hinges on timely screening and diagnosis, followed by treatment of amenable PAVMs with transcatheter embolization in conjunction with medical management and prophylactic measures to treat and prevent complications. The purpose of this review is to highlight the clinical manifestations of PAVMs specific to patients with HHT and to detail screening and treatment strategies that can reduce the risk of developing life-threatening complications.

KW - Hereditary hemorrhagic telangiectasia (HHT)

KW - Pulmonary arteriovenous malformation (PAVM)

UR - http://www.scopus.com/inward/record.url?scp=85049390878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049390878&partnerID=8YFLogxK

U2 - 10.21037/cdt.2017.12.07

DO - 10.21037/cdt.2017.12.07

M3 - Review article

C2 - 30057878

AN - SCOPUS:85049390878

VL - 8

SP - 316

EP - 324

JO - Cardiovascular Diagnosis and Therapy

JF - Cardiovascular Diagnosis and Therapy

SN - 2223-3652

IS - 3

ER -